Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Hematology-focused biotech firm adopts shareholder rights plan
February 27th, 2006
Anormed, Inc., (AOM) announced that a special committee of the board of directors of Anormed, Inc., has been constituted to consider the matters raised by the requisition and to make recommendations to the board of directors. The special committee has been evaluating the requisition and, in consultation with its advisors, has made recommendations with respect to the convening of the special meeting to the board of directors. As a result, the board of directors has called a special meeting of shareholders to be held on April 11, 2006 in Vancouver, British Columbia, with a record date of February 28, 2006. The board of directors has...
Source: Pharma Business Week (2006-02-27)
|
